Pharma marketing 2022: More digital shifts for reps, ads and drug launches, plus reputation and the metaverse
Whether you call it the new normal, the next normal or just a major shift, pharma marketing will never be the same thanks to the Covid-19 pandemic.
From the acceleration of digital strategies and communication to reputation boosts beyond what anyone could have imagined, pharma and biotech marketing is on a permanent new path. And while some of that path is still under construction and will continue for the next several years, experts predict some defined trends for 2022.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 144,300+ biopharma pros reading Endpoints daily — and it's free.